Latest Syre News & Updates

See the latest news and media coverage for Syre. We track all announcements, press releases, and industry mentions in real time, all in one place.

Syre

Textile impact company specializing in textile-to-textile polyester recycling

syre.com

Headquarters: Stockholm, Sweden
Founded year: 2023
Company type: Public company
Number of employees: 10–80
Industry: Specialty Chemicals

Last updated Today

Latest news about Syre

In short: Syre secured $900 million in offtake agreements and advanced plans for its first gigascale textile recycling plant in Vietnam.

Company announcements

August 4 Syre

Syre approaches USD 900 million in secured offtake agreements.

The company discusses scaling textile-to-textile recycling, building production capacity, and overcoming industry challenges like collection, legislation, and funding.

June 30 Syre

Syre secures three largest circular polyester offtakes worth $900M

Demand for recycled polyester far outstrips supply by 2030; these commitments unlock factory investment and scale.

June 30 Syre

Syre shifts scaling focus to Asia per analyst Shivam Gusain

The textile recycler considers Vietnam for its clean energy and supply chain advantages, emphasizing collaboration and ambition for true scale.

March 31 Syre

Syre partners with ABB to explore textile recycling technologies

They signed an MoU to investigate ABB's automation, electrification, and digital solutions for Syre's Vietnam plant producing circular polyester from waste textiles.

Media coverage

August 5 Yahoo Finance

SYRE s Q2 Loss Narrower Than Expected, Pipeline Progresses

Spyre beats Q2 loss estimates as positive phase II pipeline progress and upcoming data readouts fuel...

June 4 Yahoo Finance

SYRE Completes Enrollment in SKYWAY Basket Study on SPY072, Stock Up

Shares of Spyre Therapeutics SYRE were up 6.3% yesterday after the company announced that enrollment...

June 4 GuruFocus

SYRE Maintains Buy Rating by Deutsche Bank -- Price Target Raise

On June 4, 2026, Deutsche Bank maintained a "Buy" rating for Spyre Therapeutics (SYRE), raising the price target to $115 from $102, reflecting a 12.75...

May 23 Newser

SYRE Q1 2026 Earnings: EPS Miss Amidst No Revenue, Focus on Pipeline Progress

Stock Discussion Group- Join our free stock community and access powerful market opportunities, portfolio growth strategies, and expert analysis designed for investors at every experience...

Never miss news about Syre

Track Syre and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Syre competitors & trending companies

Browse news for competitors to Syre and other trending companies.